Triptans vs other drugs for acute migraine

Headache

Volumn 48, Issue 9, 2008, Pages 1378-1379

  Steiner, Timothy ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TRIPTAN DERIVATIVE;

EVIDENCE BASED PRACTICE; HUMAN; LETTER; MEDICAL PRACTICE; MIGRAINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EVIDENCE-BASED MEDICINE; HUMANS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRYPTAMINES;

EID: 52549108267     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01236.x     Document Type: Letter

References (6)

1. Tfelt-Hansen P. Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment. Headache. 2008 48 : 601 605.
2. Lampl C, Voelker M, Diener H-C. Efficacy and safety of 1000 mg effervescent aspirin: Individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol. 2007 254 : 705 712.
3. British Association for the Study of Headache. Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache. BASH 2007, accessible at http://www.bash.org.uk.
4. Steiner TJ, Paemeleire K, Jensen R, et al. Couturier EGM on behalf of the European Headache Federation and Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide. European principles of management of common headache disorders in primary care. J Headache Pain. 2007 8 : S3 21.
5. World Health Organization. WHO Model List of Essential Medicines. 15th list. Geneva : WHO, 2007. Accessible at http://www.who.int/medicines/ publications/essentialmedicines/en/index.html
6. World Health Organization. The World Health Report 2001. Geneva : WHO 2001.